|
1）Collins PW, Hirsch S, Baglin TP, et al. UK Haemophilia Centre Doctorsʼ Organisation: Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctorsʼ Organisation. Blood. 2007; 109: 1870-7
|
|
|
|
2）田中一郎，天野景裕，松下 正，他．後天性血友病A診療ガイドライン．日本血栓止血誌．2011; 22: 295-322
|
|
|
|
|
|
3）天野景裕．後天性血友病Aに関する凝血学的検査の注意点．臨床病理．2009; 57: 999-1003
|
|
|
|
|
4）Biggs R, Austen DE, Denson KW, et al. The mode of action of antibodies which destroy factor VIII. II. Antibodies which give complex concentration graphs. Br J Haematol. 1972; 23: 137-55
|
|
|
|
|
|
5）Matsumoto T, Nogami K, Ogiwara K, et al. A putative inhibitory mechanism in the tenase complex responsible for loss of coagulation function in acquired haemophilia A patients with anti-C2 autoantibodies. Thromb Haemost. 2012; 107: 288-300
|
|
|
|
|
|
6）田中一郎，天野景裕，瀧 正志，他．わが国における後天性凝固因子インヒビターの実態に関する3年間の継続調査 −予後因子に関する検討−．日本血栓止血誌．2008; 19: 140-53
|
|
|
|
|
|
7）Baudo F, Collins P, Huth-Kühne A, et al. Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry. Blood. 2012; 120: 39-46
|
|
|
|
|
|
8）Tengborn L, Baudo F, Huth-Kühne A, et al. Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry. BJOG. 2012; 119: 1529-37
|
|
|
|
|
|
9）Delgado J, Jimenez-Yuste V, Hernandez-Navarro F, et al. Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. Br J Haematol. 2003; 121: 21-35
|
|
|
|
|
|
10）Collins P, Baudo F, Knoebl P, et al. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). Blood. 2012; 120: 47-55
|
|
|
|
|
|
11）Hay CR, Brown S, Collins PW, et al. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation. Br J Haematol. 2006; 133: 591-605
|
|
|
|
|
|
12）Huth-Kühne A, Baudo F, Collins P, et al. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica. 2009; 94: 566-75
|
|
|
|
|